VBIV stock forecast
Our latest prediction for VBI Vaccines, Inc.'s stock price was made on the April 24, 2020 when the stock price was at 1.12$.
In the short term (2weeks), VBIV's stock price should outperform the market by 7.49%. During that period the price should oscillate between -10.43% and +22.35%.
In the medium term (3months), VBIV's stock price should outperform the market by 28.45%. During that period the price should oscillate between -28.53% and +60.83%.Get email alerts
Create a solid portfolio with VBIV
About VBI Vaccines, Inc.
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of vaccines for infectious disease and immuno-oncology. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, the Sci-B-Vac and VBI-2601. It also develops enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -0.46$ per share.
The book value per share is 1.39$
Three months stock forecastApril 24, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|